医療用チューブの世界市場-2025～2033年

医療用チューブの世界市場は、2024年に112億5,000万米ドルに達し、2033年には224億7,000万米ドルに達すると予測され、予測期間2025年のCAGRは8.3%で成長します。

医療用チューブは、体内または医療機器と患者の間で液体、気体、その他の物質を輸送することを目的とした柔軟性のある中空の導管です。その設計は、医薬品、栄養素、その他の治療用物質を安全かつ効果的に投与するために重要です。医療用チューブは、シリコーン、PVC（ポリ塩化ビニル）、ポリウレタン、熱可塑性プラスチックなど、さまざまな生体適合性材料で構成されています。これらの素材は、柔軟性、耐久性、耐薬品性に優れています。この適応性により、医療用チューブは、静脈内治療、呼吸補助、外科手術など、さまざまな用途に使用することができます。

低侵襲処置に対する需要の増加が、予測期間中の市場を牽引する要因です。低侵襲処置の需要の増加により、カテーテルのようなデバイスの製造と発売は急増しており、技術の進歩は最近発売された製品にも実装されています。例えば、2024年5月、PenumbraはMIDWAY 43およびMIDWAY 62デリバリーカテーテルを発売しました。これは、神経血管系における様々な塞栓療法のデリバリーのための最適な追跡と安定したプラットフォームを提供することを目的としています。PenumbraのREDカテーテル技術に基づくこれらのMIDWAY中間カテーテルは、中間アクセス装置業界における実質的な改善です。

市場力学：

促進要因と抑制要因

低侵襲手技に対する需要の増加

切開創が小さく身体へのダメージが少ない低侵襲手術は、そのさまざまな利点から従来の開腹手術に徐々に取って代わりつつあります。低侵襲手術は多くの場合、回復時間の短縮、合併症リスクの低減、術後疼痛の軽減、入院期間の短縮につながります。その結果、患者もヘルスケア従事者もこれらの手術をますます採用するようになり、その実施に必要な専門的な医療用チューブの需要が高まっています。

医療用チューブは、循環器科、消化器科、泌尿器科、脳神経外科などの医療専門分野において、幅広い低侵襲治療に不可欠です。例えば、血管形成術や内視鏡治療において、カテーテルやガイドワイヤーは重要なコンポーネントです。これらのチューブは、患者の安全性を維持しながら、薬物や器具をうまく送達できるように精密に設計されなければなりません。内視鏡検査の件数は日々増加しています。この数の増加が医療用チューブの需要を高めています。例えば、2024年の世界調査によると、外科医の約32％が年間100件以上の内視鏡検査を実施していると回答しています。さらに、調査対象となった外科医の13.6パーセントが、1年間に50～99件の内視鏡検査を実施しています。

先端技術を駆使した様々な医療分野における医療用チューブの製品が、ここ最近発売されています。例えば、半導体ソリューションメーカーのOmnivisionは2023年1月、単回使用内視鏡用の超薄型医療用ケーブルモジュール「OVMed OCHTA」を発表しました。この新しいモジュールは、脊椎、産婦人科、子宮腎臓、神経、眼科、心臓手術などの低侵襲手術で使用される内視鏡用に設計されています。OVMed OCHTAケーブルモジュールは6本のワイヤーを備えており、メーカーは独自のLED照明を追加することができます。

高い製造コスト

高い製造コストなどの要因が、医療用チューブの世界市場を阻害すると予想されています。医療用チューブの製造には多くの高度な部品や工程が必要であり、その一つひとつが全体的な支出を増加させています。高品質の原材料、規制遵守の制限、革新的な製造手順はすべて、製造コストの上昇につながります。例えば、医療用シリコーンは、従来のポリマーと比較して製造コストを20～30％上昇させる可能性があります。押出成形機は、その複雑さと生産能力によって、10万米ドルから50万米ドルの幅があります。押出成形機は、チューブ全体の均一性を確保するために不可欠です。これらの材料費、押出成形機費用、法規制遵守の認可費用を合計すると、高額になり、それが生産高を高くし、市場の妨げとなっています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
  • 低侵襲手術の需要増加
  • 抑制要因
  • 高い生産コスト
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 償還分析
• 特許分析
• SWOT分析
• DMIの見解

第6章 デバイスタイプ別

• シリコーン
• ポリオレフィン
• ポリ塩化ビニル
• ポリカーボネート
• フッ素樹脂
• その他

第7章 用途別

• カテーテル
• バルク使い捨てチューブ
• ドラッグデリバリーシステム
• バイオ医薬品研究機器
• その他

第8章 構造別

• シングルルーメン
• 共押出
• マルチルーメン
• テーパーまたはバンプチューブ
• 編組チューブ

第9章 エンドユーザー別

• 病院
• 外来手術センター
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第12章 企業プロファイル

• Saint-Gobain
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• Freudenberg Medical
• W. L. Gore & Associates, Inc.
• The Lubrizol Corporation
• TE Connectivity
• Nordson Corporation
• Elkem
• RAUMEDIC AG
• Teknor Apex
• Zeus Company LLC

第13章 付録

The global medical tubing market reached US$ 11.25 billion in 2024 and is expected to reach US$ 22.47 billion by 2033, growing at a CAGR of 8.3% during the forecast period 2025-2033.

Medical tubing is a flexible, hollow conduit intended for transporting fluids, gasses, or other substances within the body or between medical devices and patients. Its design is critical for providing the safe and effective administration of medicines, nutrients, and other therapeutic substances. Medical tubing is constructed from a variety of biocompatible materials, including silicone, PVC (polyvinyl chloride), polyurethane, and thermoplastics. These materials are chosen for their flexibility, durability, and chemical resistance. This adaptability enables medical tubing to be employed in a variety of applications, including intravenous (IV) therapy, respiratory support, and surgical procedures.

The increasing demand for minimally invasive procedures is the driving factor that drives the market over the forecast period. Due to increasing demand for minimally invasive procedures, the manufacture and launch of devices like catheters are upsurging and the advancements in technology are also being implemented in the recently launched products. For instance, in May 2024, Penumbra launched the MIDWAY 43 and MIDWAY 62 delivery catheters, which are intended to provide optimal tracking and a stable platform for the delivery of various embolization therapies in the neurovasculature. Based on Penumbra's RED catheter technology, these MIDWAY intermediate catheters are a substantial improvement in the intermediate access device industry.

Market Dynamics: Drivers & Restraints

Increasing demand for minimally invasive procedures

Minimally invasive procedures, which include smaller incisions and less harm to the body, are gradually replacing traditional open surgeries due to their various benefits. These procedures often lead to speedier recovery times, lower risk of complications, less postoperative pain, and shorter hospital stays. As a result, both patients and healthcare practitioners are increasingly adopting these procedures, creating a rise in demand for specialized medical tubing required for their implementation.

Medical tubing is essential in a wide range of minimally invasive treatments in medical specialties such as cardiology, gastrointestinal, urology, and neurosurgery. For instance, catheters and guidewires are critical components in angioplasty and endoscopic treatments. These tubes must be precisely engineered to allow for the successful delivery of medicinal substances or equipment while maintaining patient safety. The number of endoscopy procedures is increasing day by day. This increase in number upsurges the demand for medical tubing. For instance, according a to global survey in 2024, around 32 percent of surgeons reported they performed over 100 endoscopy procedures a year. A further 13.6 percent of surveyed surgeons perform between 50 and 99 endoscopies in a year.

The products of medical tubing in various medical specialties using advanced technologies have been launched in recent times. For instance, in January 2023, Omnivision, a semiconductor solutions manufacturer, introduced the new OVMed OCHTA, an ultra-thin medical-grade cable module for single-use endoscopes. The new module is designed for endoscopes used in minimally invasive surgery, such as spinal, ob/gyn, utero-renal, neuro, ophthalmic, and cardiac operations. The OVMed OCHTA cable modules have a six-wire cable, enabling manufacturers to add their own LED illumination.

High production costs

Factors such as high production costs are expected to hamper the global medical tubing market. Medical tube manufacture comprises a number of sophisticated components and processes, each of which adds to the overall expenditure. High-quality raw materials, restricted regulatory compliance, and innovative manufacturing procedures all contribute to higher production costs. For instance, medical-grade silicone might raise production costs by 20-30% when compared to conventional polymers. Extrusion machinery ranges between $100,000 and $500,000, depending on its complexity and output capacity. The extrusion machinery is vital for ensuring uniformity throughout the tube. All these material costs, extrusion machine costs, and regulatory compliance approval costs sum up to a hefty amount which makes the production high and hampers the market.

Segment Analysis

The global medical tubing market is segmented based on device type, application, structure, end-user, and region.

Catheters segment is expected to dominate the global medical tubing market share

The catheters segment dominates the global medical tubing market owing to the upsurge of minimally invasive procedures, and the increasing number of applications of catheters. Catheters are especially important in domains like cardiology, urology, and gastroenterology, where catheterization is required for diagnostic and therapeutic purposes. One of the primary causes of this growth is the increased frequency of chronic diseases, which demand frequent medical interventions. Catheterization is frequently used to treat and manage conditions such as cardiovascular disease, diabetes, and urinary tract infections. For instance, catheters are increasingly used in treatments such as angioplasty and stent implantation, allowing healthcare personnel to reach blood arteries with minimal harm to adjacent tissues.

For instance, according to the National Institute of Health, heart catheterization is among the most commonly performed heart procedures. In the United States, more than 1,000,000 cardiac catheterization procedures are conducted each year. Moreover, according to the International Society for Infectious Diseases, over 100 million urinary catheters are used globally each year, which equates to approximately 200 catheters being used every minute.

Advances in catheter technology have also contributed significantly to this segment's dominance. Innovations such as biocompatible materials and specific coatings have enhanced catheter performance and safety. There are product recent launches that use revolutionary technologies for manufacturing catheters. For instance, in February 2024, CERENOVUS, Inc., a division of Johnson & Johnson MedTech, announced the launch of the CEREGLIDE 71 Intermediate Catheter, a next-generation intermediate catheter with TruCourse intended for the revascularization of patients suffering from acute ischemic stroke. So, the increasing number of minimally invasive procedures, the increasing number of catheter applications across various medical domains, technological advancements, and the latest product launches make this segment the most dominating segment.

Geographical Analysis

North America is expected to hold a significant position in the global medical tubing market share

This dominance of North America in the global medical tubing market is largely due to the huge demand for medical devices containing tubing, such as catheters, IV lines, and surgical instruments, which are required for a variety of diagnostic and therapeutic treatments, adoption of minimally invasive procedures, technological advancements and presence of top players in the region. The increasing number of catheters used and the upsurge of minimally invasive procedures are observed in this geographic region. For instance, according to the American Heart Association, Inc., Every year, more than 1 million cardiac catheterization procedures are conducted in the United States, with the primary objective of diagnosing and treating patients with suspected or confirmed coronary heart disease and related diseases.

Moreover, according to the International Society for Infectious Diseases, In the United States, an estimated 30 million indwelling urethral catheters are traded each year, with around 20% of hospitalized patients using one at any given time. The recent product launches and technological advancements are observed in this region resulting in the most dominating segment. For instance, in March 2024, Abbott launched the next iteration of its Navitor heart valve technology in the United States. Navitor Vision includes extremely visible markings. These markers aid in identifying depths ranging from 3MM to 4.5MM, hence increasing implant confidence and patient outcomes. The organization received FDA approval for its Navitor system in January 2023. It developed Navitor as the only self-expanding TAVI device that incorporates leaflets within the native valve. This design improves access to coronary arteries, allowing for future treatments to treat coronary artery disease.

The growing number of minimally invasive procedures, catheter applications in a wide range of medical disciplines, technical advances, and the introduction of novel products make North America the most dominating geographical region.

Asia Pacific is growing at the fastest pace in the global medical tubing market

The Asia Pacific region is emerging as the fastest-growing market for global medical tubing. One of the most significant drivers of growth in the Asia Pacific medical tubing market is the rising prevalence of chronic diseases that demand frequent medical treatments. The region is experiencing an increase in health problems like diabetes, cardiovascular disease, and respiratory ailments. As a result, there is an increasing demand for effective treatment alternatives that frequently require specialized medical tubing for operations such as intravenous treatments and minimally invasive surgery.

In recent times, there have been launches of products that use novel technology and help in enhancing treatment efficiency. For instance, Philips, a global pioneer in health technology, announced at India Live 2024 in New Delhi that it has established over 1500 Cath Lab (interventional suite) installations across the Indian subcontinent. Philips also announced the launch of two novel approaches designed to reduce the prevalence of cardiovascular disease (CVD) in India. OmniWire, the world's first solid core pressure wire for coronary artery interventional operations, was launched in India.

Competitive Landscape

The major global players in the global medical tubing market include Saint-Gobain, Freudenberg Medical, W. L. Gore & Associates, Inc., The Lubrizol Corporation, TE Connectivity, Nordson Corporation, Elkem, RAUMEDIC AG, Teknor Apex, Zeus Company LLC among others.

Emerging Players

Vanguard Products Corporation, Bentec Medical, and MicroLumen among others

Key Developments

• In October 2024, Boston Scientific Corporation announced that the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal atrial fibrillation (AF) has received FDA approval, as well as FDA 510(k) clearance for the new FARAVIEW Software, which will be used in conjunction with the FARAPULSE Pulsed Field Ablation (PFA) System to provide visualization for cardiac ablation procedures. These technologies are only compatible with Boston Scientific's existing cardiac mapping technology and the company's latest product, the OPAL HDx Mapping System.
• In December 2024, NuGen Medical Devices announced the launch of its InsuJet needle-free insulin delivery system in Canada. It received an initial order of 2,500, followed by a second order of 750 InsuJet starting kits plus consumables. This represents revenue of $670,000.
• In October 2024, Husky Technologies and Kriya Medical Technologies Pvt. Ltd. successfully implemented India's first ICHOR-integrated medical system, marking a significant milestone. Kriya's Chennai factory will begin manufacturing 13X100 and 13x75mm blood collection tubes as part of a new agreement.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global medical tubing market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Application
• 3.3. Snippet by End-User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
  • 4.1.2. Increasing Demand for Minimally Invasive Procedures
  • 4.1.3. Restraints
  • 4.1.4. High Production Costs
  • 4.1.5. Opportunity
  • 4.1.6. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Reimbursement Analysis
• 5.6. Patent Analysis
• 5.7. SWOT Analysis
• 5.8. DMI Opinion

6. By Device Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 6.1.2. Market Attractiveness Index, By Device Type
• 6.2. Silicone*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Polyolefins
• 6.4. Polyvinyl Chloride
• 6.5. Polycarbonates
• 6.6. Fluoropolymers
• 6.7. Others

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Catheters*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Bulk Disposable Tubing
• 7.4. Drug Delivery Systems
• 7.5. Biopharmaceutical Laboratory Equipment
• 7.6. Others

8. By Structure

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Structure
  • 8.1.2. Market Attractiveness Index, By Structure
• 8.2. Single-lumen*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Co-extruded
• 8.4. Multi-lumen
• 8.5. Tapered or bump tubing
• 8.6. Braided tubing

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Ambulatory Surgical Centers
• 9.4. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Device Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Structure
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. The U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Device Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Structure
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. UK
    • 10.3.7.3. France
    • 10.3.7.4. Italy
    • 10.3.7.5. Spain
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Device Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Structure
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Device Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Structure
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. South Korea
    • 10.5.7.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Device Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Structure
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Saint-Gobain*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Freudenberg Medical
• 12.3. W. L. Gore & Associates, Inc.
• 12.4. The Lubrizol Corporation
• 12.5. TE Connectivity
• 12.6. Nordson Corporation
• 12.7. Elkem
• 12.8. RAUMEDIC AG
• 12.9. Teknor Apex
• 12.10. Zeus Company LLC

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us